Skip to content

Clinical trials

Phase 3 Adenocarcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Country / region: Poland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20161
20181
20201
20211
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.2
Eli Lilly and Company2
AstraZeneca1
Daiichi Sankyo1
Hoffmann-La Roche1
Maia Biotechnology1
Pharmexa A/S1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma10
Stomach Neoplasms5
Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Neoplasms by Histologic Type2
Neoplasms by Site2
Pancreatic Neoplasms2
Bronchial Diseases1
Carcinoma1
Carcinoma, Bronchogenic1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.